A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer

BACKGROUND: Many emerging new drugs have recently been trialled for treatment of early and advanced breast cancer. Among these new agents paclitaxel and gemcitabine play a crucial role, mostly in patients with relapsed and metastatic disease after failure of chemotherapy with antracyclines. METHODS:...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Tomao, Silverio, Romiti, Adriana, Tomao, Federica, Di Seri, Marisa, Caprio, Giuliana, Spinelli, Gian Paolo, Terzoli, Edmondo, Frati, Luigi
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2006
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1488867/
https://ncbi.nlm.nih.gov/pubmed/16723016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-6-137
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky